Edwards Lifesciences Corp...

73.31
-1.40 (-1.87%)
At close: Feb 21, 2025, 3:54 PM
73.22
-0.12%
After-hours: Feb 21, 2025, 03:59 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Net Income 1.4B 1.52B 1.5B 823.4M 1.05B 722.2M 583.6M 569.5M 494.9M 811.1M 391.7M 293.2M 236.7M 218M 229.1M 128.9M 113M 130.5M 79.3M 1.7M 79M 55.7M -11M -272M 82M
Depreciation & Amortization 144.9M 139.6M 134.8M 107.2M 89.3M 77.4M 81.9M 71.2M 65.8M 68.6M 68.7M 57.3M 58M 56.5M 58.7M 55.6M 54.8M 56.8M 56.2M 55.7M 45.6M 40.4M 57M 74M 84M
Stock-Based Compensation 139.4M 126.8M 109.3M 92.6M 81.3M 71M 61.6M 56.9M 49.9M 48.3M 47.4M 42.1M 35M 29.3M 28.3M 28.7M 27.7M 26.6M n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -242.1M -102.5M 43.5M -36.6M 59.4M -156.4M 276.9M 114.4M 141M 134.7M 7.1M 17.8M 19.3M 6.3M 12.7M -16.1M 5.7M -700K -3.2M -10.2M -4.7M n/a 2M -27M 13M
Other Non-Cash Items 7.5M 105.8M -119M 38.3M 154.1M 126.1M 21.6M -21.9M -30.3M -24.9M -56.7M -38.4M 15.1M -40.1M -78.5M 33M 16.2M 24.7M 18.7M 119.6M 12.3M 74.6M 8M 347M 11M
Deferred Income Tax -272.1M -254.5M -41.4M -49.4M 12.1M -27.3M 17.8M -37.4M -95M -71.1M 100K 8.1M -600K -11.2M -4M -23.5M -5.6M 7.1M -13.8M 800K 5.3M -13.8M -30M n/a n/a
Change in Working Capital -526.3M -421.4M 145.3M 42.2M -204.3M -42.6M 234.2M 66.1M 64.4M 190.3M 21.5M 11.5M -29.7M -1.1M -68.3M -69.5M 4.1M -14.9M -3.6M 2.8M -19.9M -36.3M -5M -12M -1M
Operating Cash Flow 895.8M 1.22B 1.73B 1.05B 1.18B 926.8M 1B 704.4M 549.7M 1.02B 472.7M 373.8M 314.5M 251.4M 165.3M 153.2M 210.2M 230.8M 136.8M 180.6M 122.3M 120.6M 101M 137M 176M
Capital Expenditures -266.3M -264.8M -329.8M -407.3M -278.4M -241.7M -175.5M -217.4M -106.5M -93.7M -110.1M -127.7M -90.6M -63M -64M -78M -62.5M -59.4M -48.5M -42.5M -37.9M -40.7M -38M -46M -42M
Acquisitions -95.2M n/a 329.8M 407.3M -100.2M -6.2M -184.6M -5.7M -333.7M -24.1M -2.7M -35.8M -42.6M -1.2M 64M 69.6M -37M n/a n/a -137.7M n/a -19M n/a n/a -7M
Purchase of Investments -105.5M -778.9M -1.89B -861.7M -603.1M -471.9M -1.35B -1.07B -1.32B -2.13B -824.6M -593.2M -645.6M -7.3M -7.4M -1.3M -57.3M -1.8M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments 715.8M 1.36B 529.2M 777M 409.9M 801.3M 1.1B 1.09B 1.44B 1.61B 526.4M 662.3M 362.1M 2.2M 13.7M 41M 5.6M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies -75M -63.1M -359.3M -446.4M -24M -4.8M -43.1M 1.2M 2.4M 3.1M -1.7M 3.9M 3.9M 7.8M 33.8M 27.5M 6.7M 25.5M 21.3M 3.1M -25.4M -8.6M 34M -29M n/a
Investing Cash Flow 173.8M 252.3M -1.72B -531.1M -595.8M 76.7M -647.2M -211.7M -316.1M -633M -412.7M -90.5M -412.8M -61.5M 40.1M 58.8M -144.5M -35.7M -27.2M -177.1M -63.3M -68.3M -4M -75M -49M
Debt Repayment -300K -200K -1.8M -800K -10M -437.3M 176.3M 222.1M 1.9M -12.7M 409.6M 39.5M 104.4M -48.4M -84.6M 94.2M -27.9M -85.9M 59.1M 7.1M -4M -82.1M -91M 441M n/a
Common Stock Repurchased -879.6M -1.73B -512.8M -625.4M -263.3M -795.5M -763.3M -662.3M -280.1M -300.9M -496.9M -344.1M -303.4M -200M -95.5M -306.5M -130.9M -145.9M -53.5M -59.1M -49.4M -30.8M n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 168.9M 142.8M 158.3M 139.3M 157.7M 131.6M 113.8M 171.7M 119.6M 160.6M 122.2M 149M 63.8M 144.5M 21.6M 14.4M 12M 4.7M -2.8M 1M -4.4M 20.6M 13M -482M -127M
Financial Cash Flow -711M -1.58B -356.3M -486.9M -115.6M -1.1B -473.2M -268.5M -158.6M -153M 34.9M -155.6M -135.2M -103.9M -91.8M -134.1M -108.1M -193.6M 29M -20.5M -15M -69.5M -78M -37M -127M
Net Cash Flow 375.4M -94.8M -332.8M 15.8M 465M -104.2M -111.8M 211.7M 64.6M 233.4M 109.5M 139.7M -224.9M 62M 115.4M 76.9M -41M 4.2M 129.7M -12.2M 26.9M -13.5M 20M 28M n/a
Free Cash Flow 629.5M 953.4M 1.4B 647M 901M 685.1M 825.2M 487M 443.2M 928.6M 362.6M 246.1M 223.9M 188.4M 101.3M 75.2M 147.7M 171.4M 88.3M 138.1M 84.4M 79.9M 63M 91M 134M